Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02547077
Other study ID # 774875
Secondary ID
Status Completed
Phase N/A
First received September 9, 2015
Last updated May 24, 2017
Start date July 2015
Est. completion date May 2016

Study information

Verified date May 2017
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether the use of 2-octylcyanoacrylate during repair of linear cutaneous surgery wounds improves scar cosmesis compared to wound closure with 5-0 fast absorbing gut.


Description:

The purpose of this study is to determine whether the use of 2-octylcyanoacrylate during repair of linear cutaneous surgery wounds improves scar cosmesis compared to wound closure with 5-0 fast absorbing gut. The investigators will use a split wound model, where half of the wound is treated with 2-octylcyanoacrylate and the other half is repaired with 5-0 fast absorbing gut. Three-months post-surgery, the scar will be measured via the physician observer scar assessment scale, a validated scar instrument. The scar width, and adverse events will also be recorded.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date May 2016
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older

- Able to give informed consent themselves

- Patient scheduled for cutaneous surgical procedure with predicted linear closure of 3 cm of longer.

- Willing to return for follow-up visits

Exclusion Criteria:

- Mentally handicapped

- Unable to understand written and oral English

- Incarceration

- Under 18 years of age

- Pregnant Women

- Wounds with predicted closure length less than 3 cm

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Wound Closure with 2-octylcyanoacrylate

Wound Closure with 5-0 Fast Absorbing Gut Sutures


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of Scar on the Patient and Observer Scar Assessment Scale After surgical procedure, half of the subject's wound will be with 2-octylcyanoacrylate, while the other half is closed 5-0 fast absorbing gut sutures. After 3 months, subjects will return to clinic for evaluation of the cosmesis of both types of closure techniques. 3 months
Secondary Measurement of Scar Width The width of the scar will be measured 1 centimeter from the midline on both sides. There is no defined width that is considered satisfactory or not satisfactory. The measurements will be compared between subjects. 3 months
Secondary Assessment of Complications Noting the presence or absence of bleeding, dehiscence, infection or spitting sutures. 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02991755 - Use of 5-0 Prolene Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure N/A
Completed NCT02383186 - Dermal Suturing Only Versus Layered Cutaneous Closure N/A
Completed NCT02289859 - Undermining During Cutaneous Wound Closure N/A
Withdrawn NCT01352533 - Closure Techniques and Scar Appearance N/A
Completed NCT02550574 - Use of 2-octylcyanoacrylate With Full-thickness Skin Grafts N/A
Completed NCT02062866 - Evaluation of Purse-String Closure Vs Second Intention N/A